BioCentury
ARTICLE | Clinical News

SA-IGIV: Began Phase I/II trial

November 15, 1999 8:00 AM UTC

Inhibitex Inc., Alpharetta, Ga. Product: SA- IGIV Business: Infectious diseases Therapeutic category: Bacterial infection Target: MSCRAMMs Description: Antibody-based therapeutic against Microbial Sur...